Raymond James & Associates »

Akebia Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $76k 41k 1.83
2023-12-31 $37k 30k 1.24
2023-09-30 $23k 20k 1.14
2023-06-30 $11k 12k 0.92
2022-06-30 $5.0k 13k 0.39
2022-03-31 $9.0k 13k 0.70
2021-12-31 $53k 23k 2.27
2021-09-30 $64k 22k 2.86
2021-06-30 $85k 22k 3.80
2021-03-31 $75k 22k 3.38
2020-12-31 $57k 20k 2.80
2020-09-30 $27k 11k 2.54
2020-06-30 $207k 15k 13.56
2020-03-31 $106k 14k 7.61
2019-12-31 $103k 16k 6.32
2019-09-30 $84k 21k 3.93
2019-06-30 $94k 20k 4.82
2018-06-30 $386k 39k 9.97
2018-03-31 $369k 39k 9.52
2017-12-31 $588k 40k 14.86
2017-09-30 $725k 37k 19.68
2017-06-30 $525k 37k 14.38
2017-03-31 $331k 36k 9.19
2016-12-31 $352k 34k 10.41
2016-09-30 $260k 29k 9.04
2016-06-30 $172k 23k 7.50
2016-03-31 $209k 23k 9.02
2015-12-31 $309k 24k 12.91